Phathom Pharmaceuticals, Inc.
PHAT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001783183
No open-market purchases or sales by Phathom Pharmaceuticals, Inc. insiders were filed in the last 90 days; 161 institutions reported holding it in 13F filings for Q2 2026, worth $782.1M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Phathom Pharmaceuticals, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 79 | 84 | +5 |
| Shares | 24.9M | 25.5M | +623.2K (+2.5%) |
| Value | $843.6M | $819.8M | −$23.7M (−2.8%) |
New holders (13)
Institutions that held Phathom Pharmaceuticals, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| StepStone Group LP | 422,085 | $13.5M | 0.88% |
| Great Point Partners LLC | 220,863 | $7.09M | 1.68% |
| FMR LLC | 154,200 | $4.95M | 0.00% |
| Dimensional Fund Advisors LP | 39,374 | $1.26M | 0.00% |
| Woodline Partners LP | 29,903 | $960.0K | 0.02% |
| Martingale Asset Management L P | 19,908 | $640.0K | 0.01% |
| Parametric Portfolio Associates LLC | 13,640 | $438.0K | 0.00% |
| SG Americas Securities, LLC | 8,420 | $270.0K | 0.00% |
| UBS Asset Management Americas Inc | 7,514 | $241.2K | 0.00% |
| Goldman Sachs Group Inc | 7,163 | $230.0K | 0.00% |
| Quantbot Technologies LP | 1,000 | $32.0K | 0.00% |
| Captrust Financial Advisors | 25 | $1.00K | 0.00% |
| Berman Capital Advisors, LLC | 9 | $0 | 0.00% |
Sold out (8)
Institutions that held Phathom Pharmaceuticals, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Greenspring Associates, LLC | 415,277 | $14.1M |
| Marshall Wace North America L.P. | 34,436 | $1.17M |
| Marshall Wace, LLP | 29,731 | $1.01M |
| Cambridge Investment Research Advisors, Inc. | 16,300 | $552.0K |
| Engineers Gate Manager LP | 14,310 | $484.0K |
| Amundi | 4,513 | $153.0K |
| Leonteq Securities AG | 1,500 | $50.8K |
| UBS Group AG | 699 | $24.0K |